InvestorsHub Logo
Followers 101
Posts 13186
Boards Moderated 0
Alias Born 06/01/2013

Re: Staypositive1 post# 22222

Tuesday, 01/19/2021 3:41:53 PM

Tuesday, January 19, 2021 3:41:53 PM

Post# of 27659
Had posted this before but yet again

google suppressing results

In response to that post

Brookline doubles Arcturus Therapeutics PT to $64 from $32

Arcturus also has a manufacturing process to produce multiple large GMP batches of pure RNA and its recent agreement with Catalent for manufacturing LUNAR-COV19, will allow it to treat a larger population, compared with traditional messenger-RNA vaccines, he said.

https://biotuesdays.com/2020/05/11/brookline-doubles-arcturus-therapeutics-pt-to-64-from-32/

Toon Stegamann's RSV patent is for

balanced (Th1/Th2)

all the posts about the Catalent patent

& here we sit



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News